Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|April 8, 2015
Is Innate Immunity and Inflammasomes Involved in Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)?Caroline M O Volpe, Jose A Nogueira-MachadoRecent Patents on Endocrine, Metabolic & Immune Drug Discovery|August 6, 2013
The dual role of free fatty acid signaling in inflammation and therapeuticsCaroline M O Volpe, José A Nogueira-MachadoRecent Patents on Endocrine, Metabolic & Immune Drug Discovery|February 23, 2016
Inflammasome as a New Therapeutic Target for Diabetic ComplicationsCaroline M O Volpe, Paula M F Anjos, José A Nogueira-MachadoJournal of Physical Activity & Health|August 3, 2018
Quantification of NGAL in Urine of Endurance Cycling AthletesJulio Cezar Q Machado, Caroline M O Volpe, Leonardo S Vasconcellos, et al.Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|October 16, 2014
Impaired clearance of neutrophils extracellular trap (NET) may induce detrimental tissular effectPaula M F Anjos, Fernanda S Fagundes-Netto, Caroline M O Volpe, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|August 17, 2019
Atorvastatin Inhibited ROS Generation and Increased IL-1β And IL-6 Release by Mononuclear Cells from Diabetic PatientsPaula M F Dos Anjos, Caroline M O Volpe, Thaís C Miranda, et al.Experimental Parasitology|August 29, 2016
Molecular characterization of lipoamide dehydrogenase gene in Trypanosoma cruzi populations susceptible and resistant to benznidazolePaula F Dos Santos, Douglas S Moreira, Elio H Baba, et al.Diabetes & Vascular Disease Research|February 17, 2012
Soluble RAGE and malondialdehyde in type 1 diabetes patients without chronic complications during the course of the diseaseJanice S Reis, Clara A Veloso, Caroline M O Volpe, et al.Pageof 1